Ken Fisher started to build up the position in BridgeBio Pharma in Q3 2021 and continued to invest until Q4 2021. Since then they sold 764 Thousand shares. The investor sold all their shares in Q1 2022 and doesn't own any shares in BridgeBio Pharma anymore.